Mucosal TNF-alpha production in Crohn’s disease downregulated by probiotic bacteria – (10-17-02)



Mucosal TNF-alpha production in Crohn’s disease downregulated by probiotic bacteria

Research articles like this just bring tears to my eyes. Probiotics are showing efficacy and high levels of safety in a wide variety of GI conditions (and their associated systematic manifestations). Like many other natural therapies, however, their use is still rare. Here we see probiotics lowering the amount of inflammation at the mucosal level of the GI tract. Remember, this is similar to what the new class of drugs for Crohns’ and RA do–the drugs block the effect of TNF-alpha. What still surprises me is that, despite all the research on the benefits of probiotics, we still view antibiotic resistance as the major concern with rampant antibitotic use. I have always considered the destruction of natural flora as the most important bad side effect…

Gut — Abstracts: Borruel et al. 51 (5): 659

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Probiotic
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”